Truist Financial’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Truist Financial’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-33,688	Closed	-$194K	–	2809
2022 Q1	$194K	Buy	33,688 +3,235	+11%	+$29K	﹤0.01%	2539
2021 Q4	$456K	Sell	30,453 -4,757	-14%	-$86.6K	﹤0.01%	2070
2021 Q3	$923K	Buy	35,210 +2,984	+9%	+$110K	﹤0.01%	1660
2021 Q2	$1.61M	Sell	32,226 -1,230	-4%	-$55K	﹤0.01%	1402
2021 Q1	$1.54M	Buy	33,456 +9,745	+41%	+$465K	﹤0.01%	1364
2020 Q4	$1.01M	Buy	23,711 +1,986	+9%	+$75.4K	﹤0.01%	1468
2020 Q3	$886K	Buy	21,725 +6,851	+46%	+$341K	﹤0.01%	1426
2020 Q2	$814K	Buy	14,874 +5,146	+53%	+$294K	﹤0.01%	1374
2020 Q1	$509K	Buy	9,728 +4,012	+70%	+$217K	﹤0.01%	1551
2019 Q4	$278K	Buy	5,716 +2,014	+54%	+$94.3K	﹤0.01%	2196
2019 Q3	$203K	Buy	+3,702	New	+$212K	﹤0.01%	757
2019 Q2	–	Sell	-7,828	Closed	-$442K	–	801
2019 Q1	$442K	Buy	7,828 +77	+1%	+$4.59K	0.01%	595
2018 Q4	$495K	Sell	7,751 -2,178	-22%	-$154K	0.01%	555
2018 Q3	$806K	Buy	9,929 +245	+3%	+$17.9K	0.01%	504
2018 Q2	$618K	Hold	9,684	–	–	0.01%	543
2018 Q1	$376K	Buy	+9,684	New	+$339K	0.01%	624

Other funds holding TRHC

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Truist Financial's TRHC Position: Q2 2022 in Review

Truist Financial sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 33,688 shares — an estimated $194K sold.

Truist Financial first reported a position in TRHC in Q1 2018 and held it in 16 quarters. The position peaked at $1.61M in Q2 2021. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

Truist Financial reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Truist Financial sold 33,688 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $194K.
Truist Financial first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
Truist Financial's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $1.61M in Q2 2021.
96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Truist Financial's 13F filing for Q2 2022, filed 22 Jul 2022.